1 Min Read
Feb 5 (Reuters) - Nymox Pharmaceutical Corp:
* SAYS RECENTLY HAD A PRE-NDA MEETING WITH FDA; NDA FOR FEXAPOTIDE FOR BPH WILL BE SUBMITTED LATER IN 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.